A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients

NCT03241550 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Hematological Malignancy

Interventions

DRUG: isavuconazonium sulfate - intravenous
DRUG: isavuconazonium sulfate - oral

Sponsor

Astellas Pharma Global Development, Inc.

Collaborators

[object Object]